동물 실험 및 비동물 대체 시험 시장 : 기회와 전략(-2035년)

Animal testing and non-animal alternative testing refer to the range of scientific methods used to evaluate the safety, efficacy, and biological effects of drugs, chemicals, cosmetics, and medical treatments. Animal testing involves the use of living animals to study disease mechanisms and predict human responses, while non-animal alternative testing utilizes advanced approaches such as in vitro cell cultures, computer-based models, and organ-on-chip technologies to achieve similar objectives without the use of animals. The combined purpose of these approaches is to ensure reliable and accurate testing outcomes while balancing scientific advancement, ethical considerations, and regulatory requirements.

The animal testing and non-animal alternative testing market consists of revenues generated by entities (organizations, sole traders and partnerships) that provide testing services, experimental models and related scientific validation services including both animal-based testing and non-animal alternative testing methods for research, safety evaluation and regulatory compliance.

The global animal testing and non-animal alternative testing market was valued at $12,420.0 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 4.00%.

Increasing Pharmaceutical R&D Spending

During the historic period, the animal testing and non-animal alternative testing market was driven by increasing pharmaceutical R&D spending. As pharmaceutical and biotechnology companies intensified efforts to develop innovative drugs, vaccines, and biologics to address complex diseases, investment in research and development activities expanded substantially across global healthcare systems. Animal testing and emerging non-animal alternative testing methods, such as in vitro assays, organ-on-chip systems, and computational toxicology models, play a crucial role in assessing biological responses to new compounds during these early research phases. For instance, in 2023, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), a U.S.-based pharmaceutical industry association, its member companies invested approximately $100.8 billion in research and development activities worldwide, with R&D accounting for about 19.1% of total sales among member firms. Therefore, the animal testing and non-animal alternative testing market was driven by increasing pharmaceutical R&D spending during the historic period.

AI-Powered Biosimulation Supports Regulatory-Ready Non-Animal Research Approaches

Key companies in the animal testing and non-animal alternative testing market are increasingly focusing on advanced computational modeling and AI-enabled biosimulation technologies to reduce reliance on traditional animal-based preclinical studies while maintaining regulatory confidence and scientific accuracy. These innovations emphasize model-informed drug development approaches that integrate predictive analytics, mechanistic modeling, and new approach methodologies (NAMs) to accelerate drug discovery, improve safety assessment, and support ethical research practices. For instance, in April 2025, Certara, Inc., a US-based biosimulation and drug development technology company, launched Non-Animal Navigator, a strategic solution designed to help biopharmaceutical companies transition away from animal testing in line with the U.S. Food and Drug Administration's roadmap for reducing animal testing in preclinical safety studies. The solution provides regulatory guidance and integrates AI-enabled biosimulation tools, including the Simcyp Simulator platform for physiologically based pharmacokinetic (PBPK) modeling, to support predictive evaluation of biologics such as monoclonal antibodies. By combining in vitro data, biosimulation models, real-world evidence, and expert toxicology insights, the Non-Animal Navigator enables pharmaceutical companies to design compliant preclinical strategies, accelerate development timelines, and reduce costs while advancing the adoption of non-animal testing methodologies.

The global animal testing and non-animal alternative testing market is highly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 1.67% of the total market in 2024.

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is evolving with growth in the number of listed companies, greater focus on ESG and sustainability positioning, increased focus on broadening shareholder base and rising frequency of M&A and corporate restructuring.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for animal testing and non-animal alternative testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The animal testing and non-animal alternative testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider animal testing and non-animal alternative testing market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth: - Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis: - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation: - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by end user application and by end use industrial application in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth: - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
• Competitive Dashboard: - Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments: - Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations: This section includes recommendations for animal testing and non-animal alternative testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Animal Testing; Non-Animal Alternative Testing
• 2) By End User Application: Cosmetics Industry; Pharmaceutical Industry; Medical Device Industry; Other End-User Applications
• 3) By End Use Industrial Application: Basic Research; Applied Research; Regulatory Testing; Development Of New Diagnostic Methods; Breeding Of Genetically Altered Animals; Animal Cloning
• Companies Mentioned: Bio-Rad Laboratories Inc.; SGS SA; BioIVT; Evotec SE; CN Bio Innovations Ltd.
• Countries: China; India; Japan; Australia; South Korea; Taiwan; Indonesia; UK; Germany; France; Italy; Spain; Russia; USA; Canada; Brazil
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Animal Testing And Non-Animal Alternative Testing Market Definition And Segmentations
• 6.4 Market Segmentation By Type (Animal Testing And Non-Animal Alternative Testing)
• 6.5 Market Sub-Segmentation Of Animal Testing, By Animal Type (Mice, Rats, Frogs, Fish, Birds, Guinea Pigs, Hamsters, Rabbits, Sheep, Dogs, Cats, Monkeys, Pigs And Other Animal Types)
• 6.6 Market Segmentation By End User Application (Cosmetics Industry, Pharmaceutical Industry, Medical Device Industry And Other End-User Applications)
• 6.7 Market Segmentation By End Use Industrial Application (Basic Research, Applied Research, Regulatory Testing, Development Of New Diagnostic Methods, Breeding Of Genetically Altered Animals And Animal Cloning)

7 Animal Testing And Non-Animal Alternative Testing Market, Overview Of Key Products

8 Global Animal Testing And Non-Animal Alternative Testing Market Attractiveness Scoring And Analysis

• 8.1 Overview Of Market Attractiveness Framework
• 8.2 Quantitative Scoring Methodology
• 8.3 Market Attractiveness Scoring And Interpretation
  • 8.3.1 Factor-Wise Evaluation
  • 8.3.2 Strategic Implications And Recommendations

9 Animal Testing And Non-Animal Alternative Testing Market, Supply Chain Analysis

• 9.1 Overview of the Supply Chain and Ecosystem
  • 9.1.1 Resources
  • 9.1.2 Manufacturers
  • 9.1.3 Distribution
  • 9.1.4 End Users

10 Animal Testing And Non-Animal Alternative Testing Market - Macro Economic Scenario

• 10.1 Impact of Interest Rate Fluctuations
• 10.2 Impact of Inflationary Pressures
• 10.3 Impact of Geopolitical Dynamics On Supply Chains
• 10.4 Impact of the COVID-19 Pandemic And Recovery
• 10.5 Strategic Insights And Future Outlook

11 Major Market Trends

• 11.1 Key Technologies & Future Trends
  • 11.1.1 Biotechnology, Genomics And Precision Medicine
  • 11.1.2 Artificial Intelligence And Autonomous Intelligence
  • 11.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 11.1.4 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 11.1.5 Sustainability, Climate Tech And Circular Economy
• 11.2 Major Trends
  • 11.2.1 Innovations In In Vitro Modeling Enhance Drug Development While Reducing Animal Use
  • 11.2.2 AI-Powered Biosimulation Supports Regulatory-Ready Non-Animal Research Approaches
  • 11.2.3 Next-Generation In Vitro Platforms Enhance Precision In Toxicity And Genetic Damage Detection
  • 11.2.4 Technology-Driven Advancements Strengthen The Future Of Ethical Research And Safety Testing

12 Global Animal Testing And Non-Animal Alternative Testing Growth Analysis And Strategic Analysis Framework

• 12.1 Global Animal Testing And Non-Animal Alternative Testing PESTEL Analysis
  • 12.1.1 Political
  • 12.1.2 Economic
  • 12.1.3 Social
  • 12.1.4 Technological
  • 12.1.5 Environmental
  • 12.1.6 Legal
• 12.2 Analysis Of End Use Industries (B2B Market)
  • 12.2.1 Pharmaceutical
  • 12.2.2 Academic Research
  • 12.2.3 Medical Devices
  • 12.2.4 Chemicals And Pesticides
  • 12.2.5 Cosmetics
  • 12.2.6 Other End Users

13 Global Animal Testing And Non-Animal Alternative Testing Market Size And Growth Analysis

• 13.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 13.1.1 Market Drivers 2020 - 2025
  • 13.1.2 Market Restraints 2020 - 2025
• 13.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 13.3 Forecast Growth Contributors/Factors
  • 13.3.1 Quantitative Growth Contributors
  • 13.3.2 Drivers
  • 13.3.3 Restraints

14 Global Animal Testing And Non-Animal Alternative Testing Total Addressable Market (TAM) Analysis

• 14.1 Definition And Scope of Total Addressable Market (TAM)
• 14.2 Methodology And Assumptions
  • 14.2.1 Total Addressable Market for the Animal Testing And Non-Animal Alternative Testing Market - Business To Business (B2B)
  • 14.2.2 TAM Comparison Analysis
  • 14.2.3 TAM vs Market Size Comparison

15 Global Animal Testing And Non-Animal Alternative Testing Market Segmentation

• 15.1 Global Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.2 Global Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.3 Global Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Global Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Animal Testing And Non-Animal Alternative Testing Market, Regional and Country Analysis

• 16.1 Global Animal Testing And Non-Animal Alternative Testing Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.2 Global Animal Testing And Non-Animal Alternative Testing Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Asia-Pacific Market

• 17.1 Asia-Pacific Market Summary
• 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 17.3 Asia-Pacific Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Asia-Pacific Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Asia-Pacific Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 Asia-Pacific Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.7 China Market
  • 17.7.1 China Market Summary
  • 17.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.7.3 China Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.4 China Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.5 China Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.6 China Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.8 India Market
  • 17.8.1 India Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8.2 India Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8.3 India Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8.4 India Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.9 Japan Market
  • 17.9.1 Japan Market Summary
  • 17.9.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.9.3 Japan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9.4 Japan Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9.5 Japan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9.6 Japan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.10 Australia Market
  • 17.10.1 Australia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10.2 Australia Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10.3 Australia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10.4 Australia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.11 South Korea Market
  • 17.11.1 South Korea Market Summary
  • 17.11.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.11.3 South Korea Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.11.4 South Korea Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.11.5 South Korea Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.11.6 South Korea Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.12 Taiwan Market
  • 17.12.1 Taiwan Market Summary
  • 17.12.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.12.3 Taiwan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.12.4 Taiwan Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.12.5 Taiwan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.12.6 Taiwan Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 South East Asia Market

• 18.1 South East Asia Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.3 South East Asia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 South East Asia Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 South East Asia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 South East Asia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.7 Indonesia Market
  • 18.7.1 Indonesia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.2 Indonesia Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.3 Indonesia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.4 Indonesia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Western Europe Market

• 19.1 Western Europe Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 Western Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 Western Europe Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 Western Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.6 Western Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.7 UK Market
  • 19.7.1 UK Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7.2 UK Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7.3 UK Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7.4 UK Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.8 Germany Market
  • 19.8.1 Germany Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.8.2 Germany Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.8.3 Germany Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.8.4 Germany Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.9 France Market
  • 19.9.1 France Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.9.2 France Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.9.3 France Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.9.4 France Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.10 Italy Market
  • 19.10.1 Italy Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.10.2 Italy Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.10.3 Italy Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.10.4 Italy Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.11 Spain Market
  • 19.11.1 Spain Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.11.2 Spain Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.11.3 Spain Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.11.4 Spain Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Eastern Europe Market

• 20.1 Eastern Europe Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 Eastern Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 Eastern Europe Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 Eastern Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.6 Eastern Europe Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.7 Russia Market
  • 20.7.1 Russia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7.2 Russia Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7.3 Russia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7.4 Russia Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 North America Market

• 21.1 North America Market Summary
• 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 21.3 North America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 North America Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 North America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.6 North America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.7 USA Market
  • 21.7.1 USA Market Summary
  • 21.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 21.7.3 USA Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7.4 USA Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7.5 USA Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7.6 USA Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.8 Canada Market
  • 21.8.1 Canada Market Summary
  • 21.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 21.8.3 Canada Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.8.4 Canada Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.8.5 Canada Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.8.6 Canada Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 South America Market

• 22.1 South America Market Summary
• 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 22.3 South America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.4 South America Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.5 South America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.6 South America Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.7 Brazil Market
  • 22.7.1 Brazil Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.7.2 Brazil Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.7.3 Brazil Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.7.4 Brazil Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Middle East Market

• 23.1 Middle East Market Summary
• 23.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 23.3 Middle East Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.4 Middle East Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.5 Middle East Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.6 Middle East Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Africa Market

• 24.1 Africa Market Summary
• 24.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 24.3 Africa Animal Testing And Non-Animal Alternative Testing Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.4 Africa Animal Testing And Non-Animal Alternative Testing Market, Sub-Segmentation Of Animal Testing, By Animal Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.5 Africa Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End-User Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.6 Africa Animal Testing And Non-Animal Alternative Testing Market, Segmentation By End Use Industrial Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

25 Competitive Landscape And Company Profiles

• 25.1 Animal Testing And Non-Animal Alternative Testing Market Competitive Landscape And & Market Share 2024
  • 25.1.1 Top 10 Companies (Ranked by revenue/share)
• 25.2 Company Profiles
• 25.3 Bio-Rad Laboratories Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 25.4 SGS SA (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 25.5 BioIVT (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 25.6 Evotec SE (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 25.7 CN Bio Innovations Ltd. (Company Overview, Products and Services, Business Strategy, Financial Overview)

26 Other Major And Innovative Companies

• 26.1 Emulate Inc. (Company Overview, Products and Services)
• 26.2 Japan Tissue Engineering Co. Ltd. (Company Overview, Products and Services)
• 26.3 InSphero (Company Overview, Products and Services)
• 26.4 Charles River Laboratories (Company Overview, Products and Services)
• 26.5 TissUse GmbH (Company Overview, Products and Services)
• 26.6 Inotiv (Company Overview, Products and Services)
• 26.7 Abbott Laboratories (Company Overview, Products and Services)
• 26.8 Gentronix Limited (Company Overview, Products and Services)
• 26.9 BICO GROUP (Company Overview, Products and Services)
• 26.10 Promega Corporation (Company Overview, Products and Services)
• 26.11 VITROCELL Systems GmbH (Company Overview, Products and Services)
• 26.12 MB Research Laboratories (Company Overview, Products and Services)
• 26.13 MIMETAS BV (Company Overview, Products and Services)
• 26.14 MatTek Corporation (Company Overview, Products and Services)
• 26.15 Alveolix AG (Company Overview, Products and Services)

27 Competitive Benchmarking

28 Competitive Dashboard

29 Animal Testing And Non-Animal Alternative Testing Market - Company Scoring Matrix

• 29.1 Innovation & Brand Leaders
• 29.2 Brand-Driven Traditionalists
• 29.3 Niche or Regional Followers
• 29.4 Emerging Innovators

30 Upcoming Startups In the Animal Testing And Non-Animal Alternative Testing Market

31 Key Mergers And Acquisitions

• 31.1 Merck KGaA Acquired HUB Organoids

32 Recent Developments In The Animal Testing And Non-Animal Alternative Testing Market

• 32.1 Regulatory Support And Public Funding Accelerate Adoption Of Non-Animal Testing Methods
• 32.2 Academic Collaborations Drive Development Of Organ-On-Chip Alternatives To Animal Testing

33 Opportunities And Strategies

• 33.1 Global Animal Testing And Non-Animal Alternative Testing Market In 2030 - Countries Offering Most New Opportunities
• 33.2 Global Animal Testing And Non-Animal Alternative Testing Market In 2030 - Segments Offering Most New Opportunities
• 33.3 Global Animal Testing And Non-Animal Alternative Testing Market In 2030 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34 Animal Testing And Non-Animal Alternative Testing Market, Conclusions And Recommendations

• 34.1 Conclusions
• 34.2 Recommendations
  • 34.2.1 Product
  • 34.2.2 Place
  • 34.2.3 Price
  • 34.2.4 Promotion
  • 34.2.5 People

35 Appendix

• 35.1 Geographies Covered
• 35.2 Market Data Sources
• 35.3 Research Methodology
• 35.4 Currencies
• 35.5 The Business Research Company
• 35.6 Copyright and Disclaimer